Fingerprint
Dive into the research topics where Ronan Swords is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML
Jain, J., Pugh, K., Handa, S., Dvorak-Kornaus, K. M., Zhao, Q., Walter, R. B., Cook, R., Saultz, J., Swords, R., Li, J., Laszlo, G. S., Grieselhuber, N. R., Mims, A. S., Larkin, K. T. M., Sahasrabudhe, K., Blachly, J. S., Behbehani, G. K., Eisfeld, A. K., Long, M. & Srisuwananukorn, A. & 2 others, , Feb 1 2026, In: Blood Neoplasia. 3, 1, 100171.Research output: Contribution to journal › Article › peer-review
Open Access -
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML
Watts, J., Nong, T., Micin, K., Soong, D., Madarang, E., Affer, M., Mehra, S., Lesmes, J. A., Chapman, J., Zhou, Y., Thomassen, A., Bradley, T., Totiger, T., Swords, R. & Taylor, J., Dec 1 2025, In: npj Precision Oncology. 9, 1, 211.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial
Hoff, F. W., Huang, Y., Welkie, R. L., Swords, R. T., Traer, E., Stein, E. M., Lin, T. L., Patel, P. A., Collins, R. H., Baer, M. R., Duong, V. H., Blum, W. G., Arellano, M. L., Stock, W., Odenike, O., Redner, R. L., Kovacsovics, T., Deininger, M. W., Zeidner, J. F. & Olin, R. L. & 19 others, , Dec 1 2025, In: Blood cancer journal. 15, 1, 55.Research output: Contribution to journal › Letter › peer-review
Open Access6 Link opens in a new tab Scopus citations -
Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study
Lachowiez, C. A., Heiblig, M., Requena, G. A., Tavernier-Tardy, E., Dai, F., Ashango, A. B., Peters, D. T., Fang, J., Kaempf, A., Long, N., Eide, C. A., Kurtz, S. E., Xie, W., Agarwal, A., Sahasrabudhe, A., McMahon, C. M., Amaya, M. L., Meyers, G., Gandhi, A. & Leonard, J. & 12 others, , Sep 1 2025, In: Blood cancer discovery. 6, 5, p. 437-449 13 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML
Zeidner, J. F., Lin, T. L., Welkie, R. L., Curran, E., Koenig, K., Stock, W., Madanat, Y. F., Swords, R., Baer, M. R., Blum, W., Stein, E. M., Olin, R. L., Schiller, G., Nichols, A., Odenike, O., Traer, E., Lachowiez, C., Duong, V. H., Hochman, M. J. & Cai, S. F. & 13 others, , Aug 10 2025, In: Journal of Clinical Oncology. 43, 23, p. 2606-2615 10 p.Research output: Contribution to journal › Article › peer-review
Open Access24 Link opens in a new tab Scopus citations